Maynard Um
-
-
-
-
-
-
-
Annexon (ANNX) Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS)
-
-
-
-
-
-
-
Annexon Biosciences (ANNX) PT Raised to $12 at BofA Securities
-
-
-
-
-
-
-
Annexon, Inc. (ANNX) Reports In-Line Q2 EPS
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

